Hainan Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hainan Ren has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Naoko Mori
Department of Radiology, Akita University Graduate School of Medicine , 1-1-1 Hondo, Akita 010-8543
8 shared publications - Kei Takase
Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
6 shared publications - Shunji Mugikura
Department of Diagnostic Radiology, Graduate School of Medicine, Tohoku University, Sendai, Japan
6 shared publications - Atsushi Masamune
Division of Gastroenterology, Tohoku University Hospital, Sendai, Japan
3 shared publications - Li Jun Qian
Department of Diagnostic Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China
2 shared publications Chengwei Shao
1 shared publication
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
Systematic multi-energy DECT radiomics integrating body composition and host inflammatory-metabolic environment for preoperative prediction of early recurrence in PDAC
Background: Early recurrence (ER) after resection occurs in up to 80% of patients with pancreatic ductal adenocarcinoma (PDAC) yet remains difficult to predict preoperatively. We developed and externally validated a dual-energy CT (DECT)-based model integrating tumor radiomics and body composition to predict ER. Methods: This retrospective bicentric study included 175 patients (training: n = 128; external validation: n = 47). Radiomic features were extracted from 40-keV, 70-keV, iodine map, and fusion series; features were selected using LASSO. Body composition (fat and skeletal muscle) was quantified at L3. A support vector machine with nested cross-validation was used for model development. The final model was frozen and applied to the external cohort without re-fitting. Performance was assessed using the area under the ROC curve (AUC), calibration (Brier score), and reclassification metrics. Results: The optimal integrated model (70-keV tumor radiomics + body composition) achieved AUCs of 0.930 (training), 0.745 (cross-validation; 95% CI 0.654–0.848), and 0.836 (external validation; 95% CI 0.682–0.952). The external Brier score was 0.142. The model improved risk reclassification over the clinical baseline model (NRI = 0.31, 95% CI 0.05–0.57; IDI = 0.21, 95% CI 0.13–0.28). Skeletal muscle area contributed more to discrimination than fat-related metrics. Patients with ER had significantly lower muscle and fat indices ( p = 0.0052 and p = 0.0139). Negative correlations were found between subcutaneous fat and ALP ( p = 0.0023), skeletal muscle and ALP ( p = 0.0030). Conclusions: A systematic multi-energy DECT model integrating 70-keV radiomics and body composition predicts early recurrence in PDAC with good external discrimination (AUC = 0.836), although external calibration was miscalibrated (slope 3.67) and requires recalibration. Skeletal muscle area emerges as a key imaging biomarker, providing a non-invasive tool for personalized preoperative risk stratification.
- 18 November 2026
- Published by Springer Nature in BMC Medical Informatics and Decision Making
Open AccessSystematic multi-energy DECT radiomics integrating body composition and host inflammatory-metabolic environment for preoperative prediction of early recurrence in PDAC
Background: Early recurrence (ER) after resection occurs in up to 80% of patients with pancreatic ductal adenocarcinoma (PDAC) yet remains difficult to predict preoperatively. We developed and externally validated a dual-energy CT (DECT)-based model integrating tumor radiomics and body composition to predict ER. Methods: This retrospective bicentric study included 175 patients (training: n = 128; external validation: n = 47). Radiomic features were extracted from 40-keV, 70-keV, iodine map, and fusion series; features were selected using LASSO. Body composition (fat and skeletal muscle) was quantified at L3. A support vector machine with nested cross-validation was used for model development. The final model was frozen and applied to the external cohort without re-fitting. Performance was assessed using the area under the ROC curve (AUC), calibration (Brier score), and reclassification metrics. Results: The optimal integrated model (70-keV tumor radiomics + body composition) achieved AUCs of 0.930 (training), 0.745 (cross-validation; 95% CI 0.654–0.848), and 0.836 (external validation; 95% CI 0.682–0.952). The external Brier score was 0.142. The model improved risk reclassification over the clinical baseline model (NRI = 0.31, 95% CI 0.05–0.57; IDI = 0.21, 95% CI 0.13–0.28). Skeletal muscle area contributed more to discrimination than fat-related metrics. Patients with ER had significantly lower muscle and fat indices ( p = 0.0052 and p = 0.0139). Negative correlations were found between subcutaneous fat and ALP ( p = 0.0023), skeletal muscle and ALP ( p = 0.0030). Conclusions: A systematic multi-energy DECT model integrating 70-keV radiomics and body composition predicts early recurrence in PDAC with good external discrimination (AUC = 0.836), although external calibration was miscalibrated (slope 3.67) and requires recalibration. Skeletal muscle area emerges as a key imaging biomarker, providing a non-invasive tool for personalized preoperative risk stratification.
- Open Access
- 22 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Increased intra-myometrial vascularity adds diagnostic value to MRI for high-risk placenta accreta spectrum
Accurate prenatal diagnosis of high-risk placenta accreta spectrum (PAS) is vital for maternal safety and can mitigate severe complications. We aimed to investigate the diagnostic value of a novel MRI sign, “increased intra-myometrial vascularity (IIMV),” and to evaluate its contribution to an optimal MRI sign combination for differentiating high-risk placenta accreta spectrum (PAS), specifically placenta increta (PI) and percreta (PP), from placenta accreta (PA) or normal placenta. This retrospective study reviewed 166 high-risk pregnant women who underwent MRI. Two radiologists independently assessed the presence of the seven established risk signs from the SAR-ESUR consensus and the novel IIMV sign. The IIMV sign was defined as continuous tubular or tortuous flow-void structures confined within the myometrium, associated with architectural distortion. Univariate logistic regression and interobserver agreement (kappa statistics) were used to select significant signs, which were then incorporated into a multivariate model to construct diagnostic combinations. AUCs were compared between combinations (with and without IIMV sign) in differentiating PI + PP group from PA + Normal groups. The novel IIMV sign demonstrated the highest specificity (0.91) and was independently associated with the differentiation between the PI + PP and Normal + PA groups. The optimal sign combination, which included IIMV, placental bulge, myometrial thinning, and bladder wall interruption, achieved an area under the curve (AUC) of 0.84. In contrast, the combination without IIMV showed a decreased AUC of 0.79 ( p = 0.1203). The “increased intra-myometrial vascularity” sign is a highly specific marker for high-risk PAS. Its inclusion in an MRI-based diagnostic model improves the performance for identifying invasive placental disorders compared to combinations that do not utilize this novel sign.
- 22 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Open AccessIncreased intra-myometrial vascularity adds diagnostic value to MRI for high-risk placenta accreta spectrum
Accurate prenatal diagnosis of high-risk placenta accreta spectrum (PAS) is vital for maternal safety and can mitigate severe complications. We aimed to investigate the diagnostic value of a novel MRI sign, “increased intra-myometrial vascularity (IIMV),” and to evaluate its contribution to an optimal MRI sign combination for differentiating high-risk placenta accreta spectrum (PAS), specifically placenta increta (PI) and percreta (PP), from placenta accreta (PA) or normal placenta. This retrospective study reviewed 166 high-risk pregnant women who underwent MRI. Two radiologists independently assessed the presence of the seven established risk signs from the SAR-ESUR consensus and the novel IIMV sign. The IIMV sign was defined as continuous tubular or tortuous flow-void structures confined within the myometrium, associated with architectural distortion. Univariate logistic regression and interobserver agreement (kappa statistics) were used to select significant signs, which were then incorporated into a multivariate model to construct diagnostic combinations. AUCs were compared between combinations (with and without IIMV sign) in differentiating PI + PP group from PA + Normal groups. The novel IIMV sign demonstrated the highest specificity (0.91) and was independently associated with the differentiation between the PI + PP and Normal + PA groups. The optimal sign combination, which included IIMV, placental bulge, myometrial thinning, and bladder wall interruption, achieved an area under the curve (AUC) of 0.84. In contrast, the combination without IIMV showed a decreased AUC of 0.79 ( p = 0.1203). The “increased intra-myometrial vascularity” sign is a highly specific marker for high-risk PAS. Its inclusion in an MRI-based diagnostic model improves the performance for identifying invasive placental disorders compared to combinations that do not utilize this novel sign.
- 27 April 2022
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 40 (9) , 876-893
American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists
IgG4-related disease (IgG4-RD) is an immune-mediated, multiorgan, chronic inflammatory disease. The three-step classification criteria proposed in 2019 by the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) encompass a wide range of clinical, radiological, serological, and histopathological findings. The ACR/EULAR proposed a three-step classification process, i.e., entry step, exclusion step, and scoring system. Radiologists need to know that the radiological findings observed in the five domains of the lacrimal and salivary glands, chest, pancreas and biliary ducts, kidney, and retroperitoneum are independently weighted with different points in the scoring system. A total score < 20 points indicates that the patient should not be classified as having IgG4-RD; conversely, a total score ≥ 20 points indicates that the patient should be classified as having IgG4-RD. In this review, the 2019 ACR/EULAR classification criteria are discussed, focusing on the interpretation of each radiological item, with the aim of applying them to the diagnosis of IgG4-RD in clinical practice.
- 27 April 2022
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 40 (9) , 876-893
American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists
IgG4-related disease (IgG4-RD) is an immune-mediated, multiorgan, chronic inflammatory disease. The three-step classification criteria proposed in 2019 by the American College of Rheumatology and the European League Against Rheumatism (ACR/EULAR) encompass a wide range of clinical, radiological, serological, and histopathological findings. The ACR/EULAR proposed a three-step classification process, i.e., entry step, exclusion step, and scoring system. Radiologists need to know that the radiological findings observed in the five domains of the lacrimal and salivary glands, chest, pancreas and biliary ducts, kidney, and retroperitoneum are independently weighted with different points in the scoring system. A total score < 20 points indicates that the patient should not be classified as having IgG4-RD; conversely, a total score ≥ 20 points indicates that the patient should be classified as having IgG4-RD. In this review, the 2019 ACR/EULAR classification criteria are discussed, focusing on the interpretation of each radiological item, with the aim of applying them to the diagnosis of IgG4-RD in clinical practice.
- 22 February 2022
- Published by Elsevier in Clinical Imaging
- Vol. 85, 8-9
Grading of placental accrete spectrum using texture analysis of magnetic resonance imaging
- 22 February 2022
- Published by Elsevier in Clinical Imaging
- Vol. 85, 8-9
Grading of placental accrete spectrum using texture analysis of magnetic resonance imaging
- 15 November 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (2) , 905-906
Letter to the editor on “High signal intensity on diffusion‐weighted magnetic resonance images is a useful finding for detecting early‐stage pancreatic cancer”
- 15 November 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (2) , 905-906
Letter to the editor on “High signal intensity on diffusion‐weighted magnetic resonance images is a useful finding for detecting early‐stage pancreatic cancer”
- Open Access
- 12 October 2021
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 11, 54-7
Abnormal Findings on “T1WI or DWI or MRCP:” An Effective Boolean Interpretation Model in Discriminating Small Pancreatic Ductal Adenocarcinoma from Control Group
Objectives: The objectives of the study was to evaluate the diagnostic performance of findings on T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and magnetic resonance cholangiopancreatography (MRCP) separately and to identify an optimal Boolean interpretation model for discriminating patients with small pancreatic ductal adenocarcinoma (PDAC) from control groups in clinical practice. Material and Methods: We retrospectively enrolled 30 patients with surgery confirmed small PDAC (≤20 mm) and 302 patients without pancreatic abnormality between April 2008 and February 2020. The presence of masses was evaluated by T1WI, T2WI, and DWI. Abnormality of the main pancreatic duct (MPD) was evaluated by T2WI and MRCP. Multivariate logistic regression analysis was performed to select significant sequences for discriminating the small PDAC and control groups. Boolean operators “OR” or “AND” were used to construct sequence combinations. Diagnostic performances of these sequences and combinations were evaluated by X2 tests. Results: The sensitivity of T2WI was lowest (20%) for detecting masses. For evaluating MPD abnormality, sensitivity was higher for MRCP than for T2WI (86.7% vs. 53.3%). Multivariate logistic regression analysis showed that T1WI and DWI for detecting the presence of masses and MRCP for evaluating MPD abnormality were significantly associated with differentiation between the two groups (P = 0.0002, P = 0.0484, and P < 0.0001, respectively). Seven combinations were constructed with T1WI, DWI, and MRCP. The combination of findings on “T1WI or DWI or MRCP” achieved the highest sensitivity of 96.7% and negative predictive value of 99.6%. Conclusion: The combination of findings on “T1WI or DWI or MRCP” might be an optimal interpretation model for discriminating small PDAC from control groups in clinical practice.
- 12 October 2021
- Published by Scientific Scholar in Journal of Clinical Imaging Science
- Vol. 11, 54-7
Open AccessAbnormal Findings on “T1WI or DWI or MRCP:” An Effective Boolean Interpretation Model in Discriminating Small Pancreatic Ductal Adenocarcinoma from Control Group
Objectives: The objectives of the study was to evaluate the diagnostic performance of findings on T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and magnetic resonance cholangiopancreatography (MRCP) separately and to identify an optimal Boolean interpretation model for discriminating patients with small pancreatic ductal adenocarcinoma (PDAC) from control groups in clinical practice. Material and Methods: We retrospectively enrolled 30 patients with surgery confirmed small PDAC (≤20 mm) and 302 patients without pancreatic abnormality between April 2008 and February 2020. The presence of masses was evaluated by T1WI, T2WI, and DWI. Abnormality of the main pancreatic duct (MPD) was evaluated by T2WI and MRCP. Multivariate logistic regression analysis was performed to select significant sequences for discriminating the small PDAC and control groups. Boolean operators “OR” or “AND” were used to construct sequence combinations. Diagnostic performances of these sequences and combinations were evaluated by X2 tests. Results: The sensitivity of T2WI was lowest (20%) for detecting masses. For evaluating MPD abnormality, sensitivity was higher for MRCP than for T2WI (86.7% vs. 53.3%). Multivariate logistic regression analysis showed that T1WI and DWI for detecting the presence of masses and MRCP for evaluating MPD abnormality were significantly associated with differentiation between the two groups (P = 0.0002, P = 0.0484, and P < 0.0001, respectively). Seven combinations were constructed with T1WI, DWI, and MRCP. The combination of findings on “T1WI or DWI or MRCP” achieved the highest sensitivity of 96.7% and negative predictive value of 99.6%. Conclusion: The combination of findings on “T1WI or DWI or MRCP” might be an optimal interpretation model for discriminating small PDAC from control groups in clinical practice.
- 7 September 2021
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (12) , 4502-4503
Letter to “Development and validation of a magnetic resonance imaging‐based nomogram for predicting invasive forms of placental accreta spectrum disorders”
- 7 September 2021
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 47 (12) , 4502-4503
Letter to “Development and validation of a magnetic resonance imaging‐based nomogram for predicting invasive forms of placental accreta spectrum disorders”
- 30 July 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (11) , 5344-5352
Prediction of placenta accreta spectrum using texture analysis on coronal and sagittal T2-weighted imaging
Purpose To separately perform visual and texture analyses of the axial, coronal, and sagittal planes of T2-weighted images and identify the optimal method for differentiating between the normal placenta and placenta accreta spectrum (PAS). Methods Eighty consecutive patients (normal group, n = 50; PAS group, n = 30) underwent preoperative MRI. A scoring system (0–2) was used to evaluate the degree of abnormality observed in visual analysis (bulging, abnormal vascularity, T2 dark band, placental heterogeneity). The axial, coronal, and sagittal planes were manually segmented separately to obtain texture features, and seven combinations were obtained: axial; coronal; sagittal; axial and coronal; axial and sagittal; coronal and sagittal; and axial, coronal, and sagittal. Feature selection using the least absolute shrinkage and selection operator method and model construction using a support vector machine algorithm with k-fold cross-validation were performed. AUC was used to evaluate diagnostic performance. Results The AUC of visual analysis was 0.75. The model ‘coronal and sagittal’ had the highest AUC (0.98) amongst the seven combinations. The fivefold cross-validation for the model ‘coronal and sagittal’ showed AUCs of 0.85 and 0.97 in training and validation sets, respectively. The AUC of the model ‘coronal and sagittal’ for all subjects was significantly higher than that of visual analysis (0.98 vs. 0.75; p < 0.0001). Conclusion The model ‘coronal and sagittal’ can accurately differentiate between the normal placenta and PAS, with a significantly better diagnostic performance than visual analysis. Texture analysis is an optimal method for differentiating between the normal placenta and PAS.
- 30 July 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (11) , 5344-5352
Prediction of placenta accreta spectrum using texture analysis on coronal and sagittal T2-weighted imaging
Purpose To separately perform visual and texture analyses of the axial, coronal, and sagittal planes of T2-weighted images and identify the optimal method for differentiating between the normal placenta and placenta accreta spectrum (PAS). Methods Eighty consecutive patients (normal group, n = 50; PAS group, n = 30) underwent preoperative MRI. A scoring system (0–2) was used to evaluate the degree of abnormality observed in visual analysis (bulging, abnormal vascularity, T2 dark band, placental heterogeneity). The axial, coronal, and sagittal planes were manually segmented separately to obtain texture features, and seven combinations were obtained: axial; coronal; sagittal; axial and coronal; axial and sagittal; coronal and sagittal; and axial, coronal, and sagittal. Feature selection using the least absolute shrinkage and selection operator method and model construction using a support vector machine algorithm with k-fold cross-validation were performed. AUC was used to evaluate diagnostic performance. Results The AUC of visual analysis was 0.75. The model ‘coronal and sagittal’ had the highest AUC (0.98) amongst the seven combinations. The fivefold cross-validation for the model ‘coronal and sagittal’ showed AUCs of 0.85 and 0.97 in training and validation sets, respectively. The AUC of the model ‘coronal and sagittal’ for all subjects was significantly higher than that of visual analysis (0.98 vs. 0.75; p < 0.0001). Conclusion The model ‘coronal and sagittal’ can accurately differentiate between the normal placenta and PAS, with a significantly better diagnostic performance than visual analysis. Texture analysis is an optimal method for differentiating between the normal placenta and PAS.
- 10 October 2020
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (4) , 1640-1647
Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma
Purpose To evaluate the diagnostic performance of apparent diffusion coefficient (ADC) parameters by region of interest (ROI) methods in differentiating mass-forming autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC). Methods The institutional review board approved this retrospective study and the requirement for informed consent was waived. Twenty-three patients with mass-forming AIP and 144 patients with PDAC underwent diffusion-weighted imaging with b-values of 0 s/mm2 and 800 s/mm2. The minimum, maximum, and mean ADC values obtained by placing ROIs within lesions and percentile ADC values (10th, 25th, 50th, 75th, and 90th) from entire-lesion histogram analysis were compared between the two groups by using Mann–Whitney U tests. The diagnostic performance was evaluated by receiver operating characteristic (ROC) curve analysis. Results The minimum, maximum, and mean ADC values were significantly different between mass-forming AIP and PDAC groups. ROC curve analysis showed that the maximum ADC had the highest diagnostic performance (0.92), while the minimum ADC value had the lowest diagnostic performance (0.72). The AUC of minimum ADC was significantly lower than that of maximum or mean ADC (P < 0.0001, P < 0.0001). The AUC was lowest in 10th percentile ADC value and highest in 90th percentile value. The AUC increased along with the increase of percentile values. Conclusion Either the maximum or mean ADC value was effective in differentiating mass-forming AIP from the PDAC group, while the minimum ADC value might not be recommended.
- 10 October 2020
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (4) , 1640-1647
Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma
Purpose To evaluate the diagnostic performance of apparent diffusion coefficient (ADC) parameters by region of interest (ROI) methods in differentiating mass-forming autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC). Methods The institutional review board approved this retrospective study and the requirement for informed consent was waived. Twenty-three patients with mass-forming AIP and 144 patients with PDAC underwent diffusion-weighted imaging with b-values of 0 s/mm2 and 800 s/mm2. The minimum, maximum, and mean ADC values obtained by placing ROIs within lesions and percentile ADC values (10th, 25th, 50th, 75th, and 90th) from entire-lesion histogram analysis were compared between the two groups by using Mann–Whitney U tests. The diagnostic performance was evaluated by receiver operating characteristic (ROC) curve analysis. Results The minimum, maximum, and mean ADC values were significantly different between mass-forming AIP and PDAC groups. ROC curve analysis showed that the maximum ADC had the highest diagnostic performance (0.92), while the minimum ADC value had the lowest diagnostic performance (0.72). The AUC of minimum ADC was significantly lower than that of maximum or mean ADC (P < 0.0001, P < 0.0001). The AUC was lowest in 10th percentile ADC value and highest in 90th percentile value. The AUC increased along with the increase of percentile values. Conclusion Either the maximum or mean ADC value was effective in differentiating mass-forming AIP from the PDAC group, while the minimum ADC value might not be recommended.